UBS O'Connor’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-71,000
| Closed | -$2.9M | – | 415 |
|
|
2024
Q3 | $2.9M | Buy |
+71,000
| New | +$2.9M | 0.07% | 132 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 487 |
|
|
2023
Q4 | – | Sell |
-209,552
| Closed | -$7.6M | – | 477 |
|
|
2023
Q3 | $7.6M | Buy |
209,552
+85,000
| +68% | +$3.08M | 0.14% | 79 |
|
|
2023
Q2 | $4.44M | Buy |
124,552
+6,136
| +5% | +$219K | 0.09% | 137 |
|
|
2023
Q1 | $4.21M | Buy |
+118,416
| New | +$4.21M | 0.1% | 155 |
|
|
2022
Q4 | – | Sell |
-165,076
| Closed | -$4.86M | – | 133 |
|
|
2022
Q3 | $4.86M | Buy |
+165,076
| New | +$4.86M | 0.06% | 221 |
|